Torthaí cuardaigh - Bhagwan Yadav

  • 1 - 17 toradh as 17 á dtaispeáint
Beachtaigh na torthaí
  1. 1
    Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells

    Identification of selective cytotoxic and synthetic lethal drug responses in triple negative breast cancer cells de réir Prson Gautam, Leena Karhinen, Agnieszka Szwajda, Sawan Kumar Jha, Bhagwan Yadav, Tero Aittokallio, Krister Wennerberg

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy

    Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy de réir Tatiana Lepikhova, Piia‐Riitta Karhemo, Riku Louhimo, Bhagwan Yadav, Astrid Murumägi, Evgeny Kulesskiy, Mikko Kivento, Harri Sihto, Reidar Grénman, Stina Syrjänen, Olli Kallioniemi, Tero Aittokallio, Krister Wennerberg, Heikki Joensuu, Outi Monni

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer

    Network pharmacology modeling identifies synergistic Aurora B and ZAK interaction in triple-negative breast cancer de réir Jing Tang, Prson Gautam, Abhishekh Gupta, Liye He, Sanna Timonen, Yevhen Akimov, Wenyu Wang, Agnieszka Szwajda, Alok Jaiswal, Dénes Türei, Bhagwan Yadav, Matti Kankainen, Jani Saarela, Julio Sáez-Rodríguez, Krister Wennerberg, Tero Aittokallio

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

    Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia de réir Heikki Kuusanmäki, Aino‐Maija Leppä, Petri Pölönen, Mika Kontro, Olli Dufva, Debashish Deb, Bhagwan Yadav, Oscar Brück, Ashwini Kumar, Hele Everaus, Bjørn Tore Gjertsen, Merja Heinäniemi, Kimmo Porkka, Satu Mustjoki, Caroline A. Heckman

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

    Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML de réir Disha Malani, Astrid Murumägi, Bhagwan Yadav, Mika Kontro, Samuli Eldfors, Ashwini Kumar, Riikka Karjalainen, Muntasir Mamun Majumder, Poojitha Ojamies, Tea Pemovska, Krister Wennerberg, Caroline A. Heckman, Kimmo Porkka, Maija Wolf, Tero Aittokallio, Olli Kallioniemi

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Mechanical forces across compartments coordinate cell shape and fate transitions to generate tissue architecture

    Mechanical forces across compartments coordinate cell shape and fate transitions to generate tissue architecture de réir Clémentine Villeneuve, Ali Hashmi, Irene Ylivinkka, Elizabeth Lawson-Keister, Yekaterina A. Miroshnikova, Carlos Pérez‐González, Satu-Marja Myllymäki, Fabien Bertillot, Bhagwan Yadav, Tao Zhang, Danijela Matic Vignjevic, Marja L. Mikkola, M. Lisa Manning, Sara A. Wickström

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia

    HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia de réir Mika Kontro, Ashwini Kumar, Muntasir Mamun Majumder, Samuli Eldfors, Alun Parsons, Tea Pemovska, Jani Saarela, Bhagwan Yadav, Disha Malani, Yngvar Fløisand, Martin Höglund, Kari Remes, Bjørn Tore Gjertsen, Olli Kallioniemi, Krister Wennerberg, Caroline A. Heckman, Kimmo Porkka

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells

    PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells de réir Otto Kauko, Caitlin M. O’Connor, Evgeny Kulesskiy, Jaya Sangodkar, Anna Aakula, Sudeh Izadmehr, Laxman Yetukuri, Bhagwan Yadav, Artur Padzik, Teemu D. Laajala, Pekka Haapaniemi, Majid Momeny, Taru Varila, Michael Ohlmeyer, Tero Aittokallio, Krister Wennerberg, Goutham Narla, Jukka Westermarck

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer

    Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer de réir Khalid Saeed, Vesa Rahkama, Samuli Eldfors, D. A. Bychkov, John Patrick Mpindi, Bhagwan Yadav, Lassi Paavolainen, Tero Aittokallio, Caroline A. Heckman, Krister Wennerberg, Donna M. Peehl, Péter Horváth, Tuomas Mirtti, Antti Rannikko, Olli Kallioniemi, Päivi Östling, Taija M. af Hällström

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1

    Phosphoproteome and drug-response effects mediated by the three protein phosphatase 2A inhibitor proteins CIP2A, SET, and PME-1 de réir Otto Kauko, Susumu Y. Imanishi, Evgeny Kulesskiy, Laxman Yetukuri, Teemu D. Laajala, Mukund Sharma, Karolina Pavic, Anna Aakula, Christian Rupp, Mikael Jumppanen, Pekka Haapaniemi, Luyao Ruan, Bhagwan Yadav, Veronika Suni, Taru Varila, Garry L. Corthals, Jüri Reimand, Krister Wennerberg, Tero Aittokallio, Jukka Westermarck

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice

    Anticancer compound ABT-263 accelerates apoptosis in virus-infected cells and imbalances cytokine production and lowers survival rates of infected mice de réir Laura Kakkola, Oxana V. Denisova, Janne Tynell, Johanna Viiliäinen, Tine Ysenbaert, Rosemary Matos, Ashwini S. Nagaraj, Tiina Öhman, Suvi Kuivanen, Henrik Paavilainen, Lin Feng, Bhagwan Yadav, Ilkka Julkunen, Olli Vapalahti, Veijo Hukkanen, Jakob Stenman, Tero Aittokallio, Emmy W. Verschuren, Päivi M. Ojala, Tuula A. Nyman, Xavier Saelens, K. Dzeyk, Denis E. Kainov

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection

    Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection de réir Oxana V. Denisova, Laura Kakkola, Lin Feng, Jakob Stenman, Ashwini S. Nagaraj, Johanna W. Lampe, Bhagwan Yadav, Tero Aittokallio, Pasi Kaukinen, Tero Ahola, Suvi Kuivanen, Olli Vapalahti, Anu Kantele, Janne Tynell, Ilkka Julkunen, Hannimari Kallio‐Kokko, Henrik Paavilainen, Veijo Hukkanen, Richard M. Elliott, Jef K. De Brabander, Xavier Saelens, Denis E. Kainov

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML

    JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML de réir Riikka Karjalainen, Tea Pemovska, Mihaela Popa, Minxia Liu, Komal Kumar Javarappa, Muntasir Mamun Majumder, Bhagwan Yadav, David Tamborero, Jing Tang, Dmitrii Bychkov, Mika Kontro, Alun Parsons, Minna Suvela, Mireia Mayoral Safont, Kimmo Porkka, Tero Aittokallio, Olli Kallioniemi, Emmet McCormack, Bjørn Tore Gjertsen, Krister Wennerberg, Jonathan C. Knowles, Caroline A. Heckman

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

    Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia de réir Disha Malani, Ashwini Kumar, Oscar Brück, Mika Kontro, Bhagwan Yadav, Monica Hellesøy, Heikki Kuusanmäki, Olli Dufva, Matti Kankainen, Samuli Eldfors, Swapnil Potdar, Jani Saarela, Laura Turunen, Alun Parsons, Imre Västrik, Katja Kivinen, Janna Saarela, Riikka Räty, Minna Lehto, Maija Wolf, Bjørn Tore Gjertsen, Satu Mustjoki, Tero Aittokallio, Krister Wennerberg, Caroline A. Heckman, Olli Kallioniemi, Kimmo Porkka

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target

    Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target de réir Olli Dufva, Matti Kankainen, Tiina Kelkka, Nodoka Sekiguchi, Shady Adnan Awad, Samuli Eldfors, Bhagwan Yadav, Heikki Kuusanmäki, Disha Malani, Emma Andersson, Paavo Pietarinen, Leena Saikko, Panu E. Kovanen, Teija Ojala, Dean A. Lee, Thomas P. Loughran, Hideyuki Nakazawa, Junji Suzumiya, Ritsuro Suzuki, Young Hyeh Ko, Won Seog Kim, Shih‐Sung Chuang, Tero Aittokallio, Wing C. Chan, Koichi Ohshima, Fumihiro Ishida, Satu Mustjoki

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

    Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia de réir Tea Pemovska, Mika Kontro, Bhagwan Yadav, Henrik Edgren, Samuli Eldfors, Agnieszka Szwajda, Henrikki Almusa, Maxim M. Bespalov, Pekka Ellonen, Erkki Elonen, Bjørn Tore Gjertsen, Riikka Karjalainen, Evgeny Kulesskiy, Sonja Lagström, Anna Lehto, Maija Lepistö, Tuija Lundán, Muntasir Mamun Majumder, Jesús M. López Martí, Pirkko Mattila, Astrid Murumägi, Satu Mustjoki, Aino Palva, Alun Parsons, Tero Pirttinen, Maria E. Rämet, Minna Suvela, Laura Turunen, Imre Västrik, Maija Wolf, Jonathan C. Knowles, Tero Aittokallio, Caroline A. Heckman, Kimmo Porkka, Olli Kallioniemi, Krister Wennerberg

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

    Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL de réir Alexandra Schrader, Giuliano Crispatzu, Sebastian Oberbeck, Petra Mayer, S. Pützer, J. von Jan, Elena Vasyutina, Kathrin Warner, Nicole Weit, Natali Pflug, Till Braun, Emma Andersson, Bhagwan Yadav, Arina Riabinska, Barbara Maurer, Mónica S. Ventura Ferreira, Fabian Beier, Janine Altmüller, Mark C. Lanasa, Carmen D. Herling, Torsten Haferlach, S. Stilgenbauer, Georg Hopfinger, Martin Peifer, Tim H. Brümmendorf, Peter Nürnberg, Kojo S.J. Elenitoba‐Johnson, Shan Zha, Michael Hallek, Richard Moriggl, Hans Christian Reinhardt, Marc‐Henri Stern, Satu Mustjoki, Sebastian Newrzela, Peter Frommolt, Marco Herling

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: